Background: Intraepithelial lymphocytes (IELs) in the intestines play pivotal roles in maintaining the integrity of the mucosa, regulating immune cells, and protecting against pathogenic invasion. Although several extrinsic factors, such as TGF-b, have been identified to contribute to IEL generation, intrinsic regulatory factors have not been determined fully. Objective: Here we investigated the regulation of IEL differentiation and the underlying mechanisms in mice.
The intestinal epithelium, which is responsible for nutrient uptake, is continuously exposed to foreign materials that can disrupt intestinal homeostasis. Epithelial cells interact with neighboring immune cells, such as intraepithelial lymphocytes (IELs), to maintain integrity, prevent pathogenic infections, and induce tolerance to dietary and commensal bacterial antigens. IELs comprise heterogeneous cell populations and are classified into 2 major subgroups based on their generation sites and characteristics: natural IELs and induced IELs. 1 Natural IELs are generated in the thymus; they are divided into T-cell receptor (TCR) gd-expressing IELs (gd IELs) and TCRab IELs (CD8aa IELs), protecting the intestinal epithelium by secreting regulatory cytokines or suppressing activated T cells. [2] [3] [4] [5] Induced IELs are generated in the mesenteric lymph nodes (mLNs) or Peyer patches. They comprise CD8ab
1 TCRab
1
IELs (CD8ab IELs) and CD4 1 TCRab 1 IELs (CD4 IELs) and protect against viral and parasitic infections. [6] [7] [8] [9] Thus IELs are crucial for maintaining intestinal homeostasis in both steady-state and infected conditions. TGF-b is a major factor influencing IELs from development to retention in the intestinal epithelium. In the thymus TGF-b inhibits apoptosis of double-negative (DN) IEL precursors by regulating antiapoptotic and proapoptotic molecules. 10 TGF-b also induces expression of CD8aa, a well-known IEL marker, in DN IEL precursors by suppressing T H cell-inducing POZKruppel factor expression. During differentiation in the periphery, TGF-b induces CD8aa expression by promoting Runt-related transcription factor 3 (Runx3) and suppressing POZ-Kruppel factor expression [10] [11] [12] and also induces CD103, another IEL marker. [12] [13] [14] Therefore regulation of TGF-b receptor (TGF-bR) is crucial for IEL differentiation. However, the molecular mechanisms of and regulators involved in TGF-bR expression during IEL differentiation are largely unknown. Because IELs are involved in intestinal homeostasis, elucidating the regulatory molecular pathways underlying IEL differentiation would contribute to the development of therapeutic and preventive approaches against intestinal diseases.
MicroRNAs (miRs) are noncoding RNAs of approximately 22 nucleotides that regulate gene expression through translational repression or degradation of target mRNAs by directly binding to their 39 untranslated region (UTR). 15 Because miRs can regulate diverse target molecules as long as the target contains the appropriate miR-binding sequence in its 39-UTR, miRs fine-tune the development, biological function, and survival of diverse cells, including immune cells. In particular, miR-150 controls the development of B, 16, 17 natural killer (NK), and NK T cells by suppressing the expression of myeloblastosis viral oncogene homolog (Myb) 18 and regulates T-cell development in the thymus by suppressing neurogenic locus notch homolog protein 3.
19 miR-150 also affects regulatory T-cell differentiation and NK cell activity by repressing mammalian target of rapamycin and regulating perforin expression, 20, 21 respectively. Although miRs, including miR-150, exert diverse effects on various cells, the roles of miRs in IEL regulation are still not clear.
In this study we demonstrated that miR-150 is critical for small intestinal IEL differentiation. miR-150 increases TGF-bRII expression by suppressing the c-Myb/miR-20a pathway. Increased TGF-bRII expression in turn increases CD103 and CD8aa expression by inducing Runx3. These results reveal an unappreciated role of miR-150 in modulating IEL differentiation and provide insight into the maintenance of intestinal homeostasis.
METHODS Mice
C57BL/6 (B6) and mir-150 2/2 mice on a B6 background were purchased from the Jackson Laboratory (Bar Harbor, Me) and kept in a specific pathogenfree facility at the Korea Research Institute of Bioscience and Biotechnology (KRIBB). All animals were treated in accordance with guidelines established by the Institutional Animal Use and Care Committee of KRIBB.
Bone marrow transfer model
Bone marrow cells (1 3 10 6 ) from B6 or mir-150 2/2 mice were transferred intravenously into lethally irradiated (900 rad) recipient mice. At 16 weeks after bone marrow transfer, the mice were killed for additional analysis.
Experimental mucositis model
Mice were injected with methotrexate (MTX; Sigma-Aldrich, St Louis, Mo) twice intraperitoneally with a 1-day interval (first injection: 120 mg/kg, second injection: 60 mg/kg), and body weight was monitored for 2 weeks. In IEL transfer experiments IELs (3.5 3 10 5 cells per mouse) were transferred intravenously at 2 days before MTX injection. (Fig 1, C) and IEL subpopulations (Fig 1, D; n 5 8 mice per genotype). E and F, Changes in body weight change (Fig 1, E) and small intestine (Fig 1, F) after MTX treatment (n 5 7 mice per group). Data (means 6 SEMs) are representative of at least 2 independent experiments. *P < .05, **P < .01, and ***P < .001. (Fig 2, C) and histologic analysis (Fig 2, D) in bone marrow-transferred mice after MTX treatment (n 5 7 mice per group). Data (means 6 SEMs) are representative of 2 independent experiments. *P < .05, **P < .01, and ***P < .001. N.S., Not significant.
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In vitro IEL differentiation
Naive CD8 1 T cells (2 3 10 5 cells per well) were cultured in 96-well plates in the presence of anti-CD3/CD28 beads (4 mL per well; Invitrogen, Carlsbad, Calif), TGF-b1 (5 ng/mL; R&D Systems, Minneapolis, Minn), and all-trans retinoic acid (RA; 1 nmol/L; Sigma-Aldrich) for 3 days. Transfection of miR-150 mimic or miR-20a inhibitor was performed with an Amaxa Nucleofector (Lonza, Basel, Switzerland), according to the manufacturer's specifications.
Statistics
Statistical differences among groups were assessed by using an unpaired 2-tailed Student t test with Prism software (GraphPad Software, La Jolla, Calif). A P value of less than .05 was considered statistically significant.
A detailed description of the methods is presented in Table E1 and the Methods section in this article's Online Repository at www.jacionline.org.
RESULTS miR-150 deficiency limits IELs in the small intestine
To assess the role of miR-150 in IELs, we investigated miR-150 expression in IELs (Fig 1, A) and the IEL population in the small intestine of wild-type (WT) and miR-150-deficient (mir-150 2/2 ) mice. mir-150 2/2 mice had significantly fewer intestinal TCRab 1 and TCRgd 1 IELs than WT mice (Fig 1, B and C). Each IEL subpopulation (gd, CD8aa, CD8ab, and CD4 IELs) was significantly reduced in mir-150 2/2 mice compared with WT mice, indicating the importance of miR-150 in IEL regulation (Fig 1, D, IELs are known to protect the intestinal barrier and repair damaged epithelial tissues by producing cytokines. 5, [22] [23] [24] [25] Given that IEL populations in the small intestine were significantly reduced by miR-150 deficiency, we hypothesized that mir-150 2/2 mice would be more susceptible to intestinal epithelial damage than WT mice. To verify this, MTX was administered to mice to damage the intestinal epithelium. 26 
MTX-administered mir-150
2/2 mice lost more body weight and required more recovery time than WT mice (Fig 1, E) . Histologic analysis also revealed that mir-150 2/2 mice exhibited increased villus degeneration with epithelial lining destruction, mucosal ulceration, and infiltration of inflammatory cells in all parts of the small intestine (Fig 1, F; /WT) and analyzed IEL populations (Fig 2, A) . All IEL subpopulations (gd, CD8aa, CD8ab, and CD4 IELs) were significantly reduced in mir-150 2/2 /WT mice compared with WT/WT control mice, whereas the number of IELs in WT/mir-150 2/2 and control mice was comparable (Fig 2, B) . When bone marrowtransferred mice were treated with MTX, mir-150 2/2 /WT mice lost more body weight (Fig 2, C) and had more damaged intestinal epithelium than WT/WT control mice (Fig 2, D; and see Fig E2, B) . These data indicate that reduced IEL populations and increased vulnerability to MTX-induced mucositis in mir-150 2/2 mice are independent of miR-150 deficiency in intestinal epithelial cells. DCs was not affected by miR-150 deficiency (Fig 3, C) . These data suggest that the reduced IEL populations in mir-150
mice are not associated with changes in the number or function of CD103
1 DCs.
Generation of IEL precursors is miR-150 independent
We next investigated the number of IEL precursors and thymic CD4/CD8
1 T-cell progenitors that further differentiate into IELs in the periphery. The total number of thymocytes and subpopulations (DN, CD8, and CD4 single positive) was similar in WT and mir-150 2/2 mice and was comparable in bone marrow-transferred mice (Fig 4, A 
miR-150 deficiency downregulates TGF-bRII expression by suppressing the c-Myb/miR-20a pathway
After the discovery that TGF-bRII expression is reduced in mir-150 2/2 IELs, the mechanism underlying the regulation of (Fig 4, A) and presented as means 6 SEMs. *P < .05 and ***P < .001. MFI, Mean fluorescence intensity.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 4 TGF-bRII expression by miR-150 was elucidated. Based on previous studies that showed suppression of TGF-bRII by mediator complex subunit 12 (MED12) and miR-20a, 36,37 we investigated whether miR-150 could modulate MED12 mRNA and miR-20a expression in IELs. Although MED12 mRNA expression was not affected by miR-150 deficiency (see Fig  E7, D) , miR-20a expression was significantly higher in mir-150 2/2 IELs than in WT IELs (Fig 6, A) . A previous report showed that miR-20a expression is induced by c-Myc. 37 Consistently, c-Myc expression was increased in mir-150 2/2 IELs (Fig  6, B) . According to miR target prediction algorithms, c-Myc has no putative binding sequences for miR-150 in its 39-UTR (data not shown). Instead, c-Myc expression can be induced by cMyb, a well-known target molecule for miR-150. 16 ,38,39 Thus we investigated whether miR-20a and c-Myc expression are increased by increased c-Myb expression in mir-150 2/2 IELs. c-Myb expression was significantly greater in mir-150
IELs than in WT IELs (Fig 6, C) , indicating that increased miR-20a and c-Myc expression was caused by enhanced cMyb expression in mir-150 2/2 IELs. Inhibition of c-Myb and TGF-bRII expression by miR-150 and miR-20a, respectively, was confirmed by using an arylalkylamine N-acetyltransferase (AANAT) reporter assay, as previously described. 21 Cotransfection of an miR-150 mimic reduced AANAT expression from the AANAT-c-Myb 39-UTR construct in a dose--dependent manner, whereas cotransfection of an miR-150 mutant lacking the binding sequence for c-Myb 39-UTR did not (see Fig E8, A, in this article's Online Repository at www.jacionline.org). Cotransfection of an miR-20a mimic also decreased AANAT expression from the AANAT-TgfbrII 39-UTR construct (see Fig E8, B) , indicating that miR-150 and miR-20a specifically inhibit c-Myb and TGF-bRII expression, respectively, as reported previously. 16, 37 These data show that reduced TGF-bRII expression in mir-150 2/2 IELs is caused by an increase in negative regulatory molecules, c-Myb, cMyc, and miR-20a. (Fig 7, A) and miR-20a (Fig 7, B) 
IELs
Given that miR-150 controls TGF-bRII expression by regulating miR-20a, we investigated the expression kinetics of miR-150 and miR-20a during IEL differentiation. miR-150 expression first increased for 6 hours and then decreased (Fig 7,  A) , whereas the change in miR-20a expression was relatively delayed (Fig 7, B) . In addition, miR-20a expression was significantly increased by miR-150 deficiency during IEL differentiation.
Next, we investigated whether miR-150 restoration or miR-20a inhibition recovered the TGF-bRII and CD103 expression in mir-150 2/2 IELs. Because naive CD8 1 T cells underwent differentiation into IELs in vitro, WT cells expressed TGF-bRII and CD103 (Fig 7, C, WT 1 miR-control) . However, mir-150 2/2 cells showed significantly decreased expression of these molecules (Fig 7, C, mir-150 2/2 1 miR-control), which is consistent with our in vivo observations of mir-150 2/2 IELs (Fig 5) . Notably, forced expression of miR-150 or inhibition of miR-20a (see Fig E9 in this article's Online Repository at www.jacionline.org) significantly increased TGF-bRII and CD103 expression in mir-150 2/2 cells (Fig 7, C, mir-150 2/2 1 miR-150 and mir-150 2/2 1 miR-20a inhibitor, respectively). Collectively, these data indicate that miR-150-induced miR-20a suppression is critical for the acquisition of IEL phenotypes through promotion of TGF-bRII expression (Fig 7, D) and that miR-150 regulates IEL differentiation by providing a molecular environment favorable for TGF-bRII expression.
DISCUSSION
TGF-b signaling is known to be critical for IEL differentiation. 10, 13 However, the regulatory mechanisms behind TGF-bR expression in IELs are still unknown. In this study we showed that miR-150 is a key regulator of TGF-bRII expression during IEL differentiation. miR-150 regulates TGF-bRII by suppressing a negative regulatory pathway (Myb/Myc/miR20a), thus inducing expression of TGF-bRII and molecules of IEL phenotypes, such as CD103 and CD8aa, during IEL differentiation.
During IEL differentiation, TGF-b-induced Runx3 upregulates expression of CD103 and CD8aa, which play important roles in IELs. CD103 is known to be important for gut tropism. Although CD103 has not been shown to be directly required for IEL migration into intraepithelial sites, it has been shown to be essential for IELs to reside in intraepithelial sites by binding to E-cadherin on intestinal epithelial cells. 1, 40 CD8aa enables IELs to reside in intraepithelial sites by binding to the thymic leukemia antigen (TLA) on intestinal epithelial cells. 1 Consequently, decreased CD103 and CD8aa expression in mir-150 2/2 IELs might negatively influence the localization of IELs after differentiation, resulting in reduced IEL populations at the intraepithelial site. In addition to gut residency, CD8aa also contributes to the survival of IELs in epithelial sites. Interaction between CD8aa and TLA is known to increase the survival of activated T cells by attenuating TCR signaling. 1, 41 Given that IELs are a partially activated population exposed to an intestinal environment with continuous high-pressure antigenic stimulation, interaction between CD8aa and TLA might support IEL survival. 42 Collectively, reduced expression of CD103 and CD8aa could result in IEL deficiency in mir-150 2/2 mice. We found that miR-150 provides a favorable molecular milieu for TGF-bRII expression during IEL differentiation. In mir-150 2/2 mice, TGF-bRII, Runx3, and CD103 expression levels were significantly decreased in all IEL populations. In addition, mir-150 2/2 IELs showed reduced TGF-bRII and CD103 levels during in vitro IEL differentiation. These reduced expression levels were restored by forced expression of miR-150, indicating that miR-150 is an inducer of TGF-bRII. Considering the significant increase in miR-20a expression in mir-150 2/2 IELs both in vivo and in vitro (Figs 6, A, and 7, B) , miR-150 might induce TGF-bRII through miR-20a expression. The increased miR-20a expression under miR-150-deficient conditions can be explained by the increased expression of c-Myc, a transcription factor for miR-20a, and c-Myb, a c-Myc-inducing protein. 16, [37] [38] [39] Moreover, miR-150 is known to act as a direct suppressor of c-Myb. 16 miR-150-mediated inhibition of c-Myb and c-Myc caused the reduced miR-20a expression. Hence miR-150 promotes TGF-bRII expression by suppressing a negative regulatory pathway (Myb/Myc/miR-20a) during IEL differentiation.
miR-150 expression is controlled by Wnt/b-catenin signaling and glucocorticoid treatment in colorectal cancer cells and multiple myeloma cells, respectively. 43, 44 However, the signal that induces miR-150 expression in T cells, including IELs, has not been identified. Studies showed that naive T cells in the spleen and lymph nodes had relatively high miR-150 levels, which were decreased by TCR stimulation with a costimulatory signal. 45 Consistent with these previous reports, miR-150 levels transiently increased and then gradually decreased during IEL differentiation, suggesting that TCR ligation/activation was not required for induction of the miR-150-TGF-bRII-CD103 axis in IELs. Rather, TCR ligation appeared to be required for CD8aa expression during IEL differentiation. TCR signaling in the presence of TGF-b-induced Runx3 epigenetically modulates the CD8a promoter region and facilitates CD8a expression. 11, 46 This TCR ligation is probably provided by the CD103 1 DCs that process intestinal bacteria and food antigens in the intestinal lumen. 47 Further studies are required to understand the underlying mechanisms controlling miR-150 expression in IELs and the role of TCR ligation in IEL differentiation.
In 2/2 mice cannot be completely attributed to reduced TGF-bRII expression and subsequently decreased CD103 levels. TCRgd 1 IEL migration was reported to be differentially regulated by occludin, another migration-associated molecule. 48 Apart from TGF-bRII and CD103, other migration-associated and/or retention-related molecules, such as occludin, might be involved in the reduction of TCRgd 1 IEL numbers in the setting of miR-150 deficiency. This possibility needs to be investigated further.
Gut-residential CD103 1 DCs play a critical role in the development of IELs by generating RA, but there were no significant differences in numbers and functions of CD103 DCs between WT and miR-150 2/2 mice (Fig 3) , indicating that miR-150 did not affect CD103
1 DCs. In addition, no potential targets of miR-150 were found among the genes required for CD8a 1 or CD103 1 DC development, such as inhibitor of DNA binding 2, interferon regulatory factor 8, and basic leucine zipper ATF-like 3 transcription factor (data not shown). [49] [50] [51] Although the level of miR-150 in CD103
1 DCs was not determined, it is plausible that miR-150 does not affect the development of CD103
1 DCs. Although we showed that mir-150 2/2 mice were more susceptible than WT mice, presumably because of reduced IEL populations (Fig 1, E and F) , we did not determine the IEL subpopulation that majorly contributed to the resistance to MTX-induced enteropathy. Many studies have addressed the protective role of IELs in intestinal inflammation. MTX-induced mucositis was more severe in IL-10 knockout mice than in WT mice, indicating that the IL-10-producing IEL population might be involved in alleviating pathogenesis. 26 In a CD4 1 T-cell transfer model of inflammatory bowel disease, transfer of CD8aa IELs before CD4
1 T-cell transfer prevented colitis development in an IL-10-dependent manner, implying that CD8aa IELs could prevent MTX-induced mucositis during early enteropathy by suppressing production of inflammatory cytokines and protecting intestinal epithelial cells from apoptosis. 24 gd IELs also prevented MTX-induced intestinal damage in a keratinocyte growth factordependent manner, indicating that gd IELs also have an important role in intestinal tissue repair. 22 Although CD4 IELs are a minor subset of IEL subpopulations, a previous study showed that they might have a protective function in bowel inflammation. 52 In a CD4
1 T-cell transfer model of colitis, TGF-bRII-deficient CD4 1 T cells had colitis because of defective differentiation of CD4 IELs.
In addition to not specifying the IEL subpopulation that played a preservative role, our study has another limitation that the role of IELs were assessed only at a single dose of MTX. The exact function of each IEL subpopulation need to be further investigated at various doses of MTX.
Our study clarified the role of miRs in IEL regulation. We found that miR-150 regulates IEL differentiation by promoting TGF-bRII expression. Given that TGF-b signaling is associated with the fate of T cells, defining regulatory factors for TGF-b signaling, such as miR-150, provides a better understanding of the fate-determining mechanisms of T cells and a basis for therapeutic and preventive treatment of T cell-associated intestinal diseases. 
METHODS Preparation of cells
IELs were isolated by using a previously reported method. E1 Briefly, the small intestines were removed, separated from Peyer patches, opened longitudinally, and cut into 0.5-cm segments. Intestinal tissues were transferred to 50-mL conical tubes containing PBS supplemented with 10 mmol/L EDTA and 1% (vol/vol) FBS, which were then shaken at 250 rpm for 30 minutes at 378C by using a shaking incubator (Hanil, Gimpo, Korea). The tissue suspension was passed through a 70-mm cell strainer (BD Biosciences, San Diego, Calif), and the cells were collected by means of centrifugation at 1500 rpm for 10 minutes. Cell pellets were resuspended in HBSS and layered over a discontinuous 40% to 70% (vol/vol) Percoll (GE Healthcare, Marlborough, Mass) gradient for 30 minutes at 2500 rpm. Then IELs were isolated from the Percoll gradient interface, washed, and resuspended in complete RPMI media.
To isolate LP cells, intestinal fragments with IELs removed were minced and digested in RPMI containing 3% FBS, 20 mmol/L HEPES, 100 U/mL penicillin, 100 mg/mL streptomycin, 1 mmol/L sodium pyruvate, 1 mmol/L nonessential amino acids, 400 U/mL collagenase D (Roche, Basel, Switzerland), and 100 mg/mL DNase I (Roche) at 378C for 45 minutes with continuous stirring. After adding 10 mmol/L EDTA and incubating for 5 minutes at 378C, the cell suspension was filtered with a cell strainer and pelleted by means of centrifugation for 5 minutes at 2000 rpm. LP cells were purified with Percoll, as described above.
The thymus, spleen, mLNs, and Peyer patches were also removed, mashed through a cell strainer, and washed. Single-cell suspensions were obtained after erythrocyte lysis. For preparation of DCs from Peyer patches and mLNs cell suspensions were incubated with RPMI containing collagenase D and DNase I, as described above.
Histology
The 3 parts (duodenum, jejunum, and ileum) of the small intestine were removed, washed in ice-cold PBS, and fixed in 4% paraformaldehyde on ice for 2 hours. Next, tissues were washed 3 times in ice-cold PBS and incubated in 30% (wt/vol) sucrose/phosphate buffer overnight. The tissue samples were embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek, Torrance, Calif) and snap-frozen by using liquid nitrogen. Ten-micrometer-thick cryostat sections were collected and dried at 258C for 30 minutes. The slide-embedded samples were incubated under MeOH at 2208C for 10 minutes, dried at room temperature for 10 minutes, washed with PBS, and blocked with anti-CD16/CD32 antibody (BD Biosciences). Then the slides were incubated with antibodies against TCRgd and TCRb and counterstained with 49-6-diamidino-2-phenylindole dihydrochloride. To assess pathology in MTX-treated mice, 4% paraformaldehyde-fixed samples were embedded with paraffin, sectioned to a thickness of 4 mm, and stained with hematoxylin and eosin.
ALDEFLUOR assay
The ALDEFLUOR assay was performed according to the manufacturer's instructions (STEMCELL Technologies, Vancouver, British Columbia, Canada). Briefly, 1 3 10 6 cells freshly isolated from mLNs, Peyer patches, or small intestinal LPs were suspended in ALDEFLUOR assay buffer (5 mL of ALDH substrate per 1 3 10 6 cells) and incubated for 1 hour at 378C. As a negative control, corresponding cells were treated with 5 ml dimethylaminobenzaldehyde, an ALDH inhibitor. The incubated samples were blocked with anti-CD16/CD32 to prevent nonspecific binding of antibodies and stained with antibodies against CD11c, MHC class II (MHC II), and CD103. Cells were then analyzed by using flow cytometry.
Reverse transcription and quantitative PCR
Total RNA was extracted with TRIzol (Invitrogen), and the samples were reverse transcribed with Moloney murine leukemia virus reverse transcriptase and oligo-dTs (Thermo Fisher Scientific, Waltham, Mass), according to the manufacturer's instructions. For real-time quantitative PCR, cDNA was amplified with ViiA 7 (Thermo Fisher Scientific) with specific primers, as described in the Online Repository. mRNA expression levels were calculated relative to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Quantitative real-time PCR for mature miRs was performed with the TaqMan MicroRNA Assay Kit (Applied Biosystems, Carlsbad, Calif), according to the manufacturer's instructions. miR expression was calculated relative to that of U6 small nuclear RNA.
Flow cytometry
The prepared single-cell suspensions were incubated with anti-CD16/ CD32 blocking antibody to prevent nonspecific binding of antibodies and fluorescence-conjugated antibodies sequentially. The antibodies were purchased from BD PharMingen (anti-CD4, 550954; anti-CD8a, 552877; anti-CD103, 557495; anti-CD122, 553361; anti-CD127, 552543; and anti-CD132, 554457) or eBioscience (San Diego, Calif; anti-CD8b, 47-0083-82; anti-CD11b, 48-0112-82; anti-CD103, 11-1031-82; anti-CD127, 25-1271-82; anti-IL-15Ra, 12-7149-82; anti-MHC II, 47-5321; anti-TCRb, 17-5961-83; and anti-TCRgd, 12-5711-82). Cell suspensions were incubated with rabbit anti2TGF-bRI (Abcam, GR243828-1) or anti2TGF-bRII (Abcam, GR83562-24) and anti-rabbit IgG Fab2 (Cell Signaling, Danvers, Mass; 44125) sequentially after blocking Fc receptor with anti-CD16/CD32, as described above, to assess expression levels of TGF-bRI and TGF-bRII. Flow cytometric data were acquired with a FACSCanto II or Beckman Coulter Gallios and analyzed with FlowJo software (TreeStar, Ashland, Ore). For measurement of CD8aa expression, phycoerythrin-conjugated TL-tetramer was used, as described previously.
E2
Plasmids and reporter assay 
Immunoblotting
Cytoplasmic lysates of the transfected cells were extracted with PBS containing 1% NP-40 and complete protease inhibitor (Roche). The lysates were incubated overnight at 48C with rabbit anti-AANAT (Abcam, ab3506) and mouse anti-b-actin (Santa Cruz Biotechnology, Dallas, Tex; sc-47778) as primary antibodies. After washing with PBS containing 0.5% Tween-20 (Sigma-Aldrich), the samples were incubated for 1 hour at room temperature with anti-rabbit IgG (Thermo Fisher Scientific, NCI1460KR) or anti-mouse IgG (Thermo Fisher Scientific, NCI1430KR), respectively, and visualized with an Immobilon Western kit (Millipore, Temecula, Calif). (Fig E5, D) , CD132 (Fig E5, E) , CD127 (Fig E5, F) , and AHR (Fig E5, G) on IELs from WT and mir-150 GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; RAR, retinoic acid receptor.
